Junel fe 1/20 and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Junel fe 1/20 (ethinyl estradiol; norethindrone acetate), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Zantac, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Insomnia when taking Junel fe 1/20. It is created by eHealthMe based on reports of 1,070 people who have side effects when taking Junel fe 1/20 from the FDA, and is updated regularly.

What is Junel fe 1/20?

Junel fe 1/20 has active ingredients of ethinyl estradiol; norethindrone acetate. It is often used in birth control. eHealthMe is studying from 1,172 Junel fe 1/20 users. Check the latest studies of Junel fe 1/20.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,115 drugs and 5,171 conditions by eHealthMe. Check the latest studies of Insomnia.

On May, 28, 2026

1,070 people reported to have side effects when taking Junel fe 1/20.
Among them, 22 people (2.06%) have Insomnia.

Among these 22 people:

How long have people been on Junel fe 1/20 when they have Insomnia? *

What is the gender of people who have Insomnia when taking Junel fe 1/20? *

female: 100 %
male: 0.0 %

What is the age of people who have Insomnia when taking Junel fe 1/20? *

What are other drugs people take besides Junel fe 1/20? *

What are other side effects people have besides Insomnia? *

Fatigue (feeling of tiredness): 7 people, 31.82%
Dizziness: 5 people, 22.73%
Headache (pain in head): 5 people, 22.73%
Stress And Anxiety: 5 people, 22.73%
Feeling Abnormal: 4 people, 18.18%
Nausea (feeling of having an urge to vomit): 4 people, 18.18%
High Blood Pressure: 3 people, 13.64%
Panic Disorder: 3 people, 13.64%
Migraine (headache): 3 people, 13.64%
Depression: 3 people, 13.64%

What are the existing conditions these people have? *

Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 9.09%
Hypersensitivity: 2 people, 9.09%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 9.09%
Depression: 2 people, 9.09%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 9.09%
Food Allergy: 2 people, 9.09%
Headache (pain in head): 2 people, 9.09%
Stress And Anxiety: 2 people, 9.09%
Bipolar Disorder (mood disorder): 1 person, 4.55%
Blood Oestrogen Increased: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Junel fe 1/20 and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Junel fe 1/20:

Junel fe 1/20 (1,172 reports)

Insomnia treatments and more:

Insomnia (438,081 reports)

How severe was Insomnia and when was it recovered:

Insomnia in Junel fe 1/20

Expand to all the drugs that have ingredients of ethinyl estradiol; norethindrone acetate:

Insomnia and drugs with ingredients of ethinyl estradiol; norethindrone acetate (498 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Junel fe 1/20:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,115 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,171 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Junel fe 1/20) and Junel fe 1/20 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.